Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma
Clinical trial NCT01767194 · COMPLETED
Trial details
- NCT number
- NCT01767194
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-12
- Primary completion
- 2018-06-30
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.